Active ingredientIobenguane HemisulfateCat. No. P-I054-001CAS 87862-25-7Family · Pharmaceutical analytical standards
Iobenguane
A noradrenaline analogue, also known as MIBG, that is taken up by cells of the sympathetic nervous system: described in 1980 and labelled with radioactive iodine, it is used to image and treat phaeochromocytomas, paragangliomas and neuroblastomas. This family brings together the active ingredient and labelled standards.
Did you know?It was created to image the adrenal medulla, but it also turned out to be a treatment: in 2018 the iodine-131 version became the first therapy approved in the United States for advanced phaeochromocytoma and paraganglioma.
Go to the active ingredient →Active ingredientIobenguane HemisulfateCat. No. P-I054-001CAS 87862-25-7
Isotopically labelledIobenguane-d4Cat. No. P-I054-002No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceIobenguane sulfate CRSEDQM code I0328000Family IobenguaneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.